New briefing highlights actions to ensure access to best-practice heart failure care in Italy

News & Events

13 April 2023
AUTHOR: Ellen McIntosh

The latest policy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Italy.

Based on extensive research and expert interviews, the briefing  recommends specific actions, including:

The current health landscape in Italy means that the quality of care for people living with heart failure varies greatly across regions. However, the National Plan for Chronic Conditions does prioritise heart failure, providing an opportunity for advocacy groups to call for the Plan’s implementation in their area to address existing inequalities in care.

This briefing is the third in our From guidelines to action series, which aims to equip national advocates with a targeted analysis of the opportunities available in their countries, along with specific actions they can take to change the narrative in their region. All of the actions are supported by successful examples from a number of health interventions and interviews with national heart failure experts. The Italian briefing follows reports on France and Spain, with a German report due to be published soon.

Download the report in English

Download the report in Italian

Tagged:

More from News & Events

European Commission answers tabled questions on heart failur
European Commission answers tabled questions on heart failur...
22 April 2024
Questions from European Heart Failure Mission Policy Champions on the need for specific heart failure funding received responses from the European Commission....
Read article
The Heart Failure Policy Summit returns in April 2024 to bri
The Heart Failure Policy Summit returns in April 2024 to bri...
18 January 2024
This April, the HFPN is delighted to host the Heart Failure Policy Summit 2024....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .